GlassScriptPhysician profile
Lauren Andreotti Murray
NPI 1740410588
$4,360.90
in general payments reported to CMS, 2019-2025
42 companies · $617 in 2025
The $617 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $48.22 · 2021: $659 · 2022: $800 · 2023: $918 · 2024: $650 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,184.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.64 | 2019-2024 | |
| Pfizer INC. | $344.75 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $334.06 | 2021-2025 | |
| Celularity INC. | $300.00 | 2019 | |
| Astellas Pharma US INC | $295.72 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $259.40 | 2023-2025 | Summit Doppler, Paragard T 380a |
| Organon LLC | $246.20 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $223.90 | 2019-2022 | |
| Myovant Sciences INC. | $214.47 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $196.83 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $127.10 | 2023-2025 | Zurzuvae |
| Exeltis, USA INC. | $124.30 | 2021-2025 | Slynd |
| Shield Therapeutics INC | $115.16 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $68.49 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Dexcom, INC. | $66.87 | 2023-2024 | Dexcom G6 Transmitter |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.